Conference Paper: Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection.

File Download
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleInterim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection.
AuthorsYuen, RMF
Kim, J
Wong, DKH
Ngai, WS
Yuen, JCH
Lai, CL
Issue Date2004
Citation39th Annual Meeting of the European Association for the Study of Liver, Berlin, Germany 14-18 Apr 2004 (published in J Hepatol) , v. 40 n. Suppl 1, p. 114 [How to Cite?]
DC Field
Value
dc.contributor.authorYuen, RMF
dc.contributor.authorKim, J
dc.contributor.authorWong, DKH
dc.contributor.authorNgai, WS
dc.contributor.authorYuen, JCH
dc.contributor.authorLai, CL
dc.date.accessioned2010-09-25T20:12:56Z
dc.date.available2010-09-25T20:12:56Z
dc.date.issued2004
dc.identifier.citation39th Annual Meeting of the European Association for the Study of Liver, Berlin, Germany 14-18 Apr 2004 (published in J Hepatol) , v. 40 n. Suppl 1, p. 114 [How to Cite?]
dc.identifier.hkuros105373
dc.identifier.issueSuppl 1
dc.identifier.spage114
dc.identifier.urihttp://hdl.handle.net/10722/101997
dc.identifier.volume, v. 40 n. Suppl 1
dc.languageeng
dc.relation.ispartof39th Annual Meeting of the European Association for the Study of Liver, Berlin, Germany 14-18 Apr 2004 (published in J Hepatol)
dc.titleInterim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection.
dc.typeConference_Paper